Nasopharyngeal Neoplasms
Recent clinical, regulatory, research and industry developments relating to this disease.
The immune escape mechanism of nasopharyngeal carcinoma.
Estimating the global burden of Epstein-Barr virus-related cancers.
EMT-associated microRNAs and their roles in cancer stemness and drug resistance.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial with recent milestones.
Clinical MilestonesViewHide
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Nasopharyngeal Neoplasms4
- Breast Neoplasms1
- Carcinoma1
- Carcinoma, Hepatocellular1
- Carcinoma, Non-Small-Cell Lung1
- Cholangiocarcinoma1
- Epstein-Barr Virus Infections1
- Immune Checkpoint Inhibitors1
Leading journals5
- Annals of medicine1
- Cancer communications (London, England)1
- ESMO open1
- FASEB journal : official publication of the Federation of American Societies for Experimental Biology1
- Journal of cancer research and clinical oncology1
Leading researchers8
- Bai X1
- Burrows SR1
- Cao J1
- Chan SL1
- Chen Q1
- Chiu JW1
- Day D1
- Doolan DL1
Affiliations (unnormalised)6
- Auckland City Hospital1
- Australian Institute of Tropical Health and Medicine1
- Centre for Molecular Therapeutics1
- Centre for Tropical Bioinformatics and Molecular Biology1
- Clinical Laboratory1
- Department of Clinical Oncology1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Nasopharyngeal neoplasms are tumors or cancers arising in the nasopharynx. The supplied literature specifically highlights nasopharyngeal carcinoma as a major malignant form in this site.
Epstein-Barr virus (EBV) infection is closely related to the pathogenesis of nasopharyngeal carcinoma. The grounding does not support additional specific causes for nasopharyngeal neoplasms as a broader category.
The literature describes a tumor microenvironment that supports immune escape, invasion, metastasis, treatment resistance, and recurrence. In nasopharyngeal carcinoma, co-existence of EBV-infected tumor cells and tumor-infiltrating lymphocytes creates a distinctive, heterogeneous, and suppressive microenvironment that promotes tumorigenesis.
EBV infection is the supported risk factor in the supplied grounding. The grounding does not provide additional risk factors for nasopharyngeal neoplasms.
The supplied grounding does not support a general standard-of-care treatment description for nasopharyngeal neoplasms. It only indicates that understanding immune escape mechanisms may help identify immunotherapy targets and develop immunotherapy drugs, and that next-generation sequencing can have clinical utility in some metastatic cancers undergoing targeted drug therapies.
AI-generated summary grounded in MeSH and 4 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Tumors or cancer of the NASOPHARYNX.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.